ICU · renal-metabolic
Acute Severe Rhabdomyolysis — Comprehensive ICU Management
Also known as Rhabdomyolysis · Rhabdo · Myoglobinuria · Crush syndrome · Muscle breakdown · Creatine kinase elevation · Myoglobin nephrotoxicity · Exertional rhabdomyolysis · Statin-induced rhabdomyolysis
Rhabdomyolysis — skeletal muscle breakdown releasing intracellular contents (myoglobin, creatine kinase, potassium, phosphate, urate) into the circulation → AKI (myoglobin nephrotoxicity + intratubular cast formation + volume depletion), hyperkalaemia (lethal arrhythmia), hypocalcaemia, metabolic acidosis, compartment syndrome. Causes: crush injury (trauma, building collapse, prolonged immobilisation), exertional (marathon, seizures, agitation/delirium), drugs (statins 1 — especially with fibrates/calcineurin inhibitors, illicit drugs — MDMA, cocaine, heroin), infections (influenza, legionella, coxsackie, severe sepsis), metabolic (hypokalaemia, hypophosphataemia, DKA/HHS), genetic (McArdle disease, CPT deficiency, malignant hyperthermia), inflammatory (polymyositis, dermatomyositis). Diagnosis: CK 5x ULN (1000 IU/L — typically 10,000-100,000+) + myoglobinuria (dark/tea-coloured urine + positive blood on dipstick but NO RBCs on microscopy) + hyperkalaemia + elevated AST/ALT (muscle-derived). Management: AGGRESSIVE IV FLUIDS (the 1 intervention — high urine flow — about 400 mL/h crystalloid, up to 12 L or more per day in severe crush — crystalloid, ideally balanced solution), treat hyperkalaemia (calcium gluconate + insulin/dextrose), urine alkalinisation (controversial — sodium bicarbonate mainly in acidotic patients — evidence is limited), renal replacement therapy if severe AKI (CRRT preferred), fasciotomy if compartment syndrome. Mortality: about 10 per cent overall, higher when AKI develops.
Checked against its sources on 2 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- CK ≥5000 IU/L (severe rhabdomyolysis) + dark urine + hyperkalaemia = RHABDOMYOLYSIS with high AKI risk — start AGGRESSIVE high-volume IV crystalloid immediately (about 400 mL/h, scaled up to 12 L or more per day in severe crush)
- Hyperkalaemia (K ≥5.5 mmol/L, seen in 13% of severe cases) can be SEVERE and REFRACTORY — potassium is continuously released from necrotic muscle — IV calcium for ECG changes or K ≥6.5, insulin–dextrose shifts K intracellularly, nebulised salbutamol 10–20 mg adds ~1.2 mmol/L of lowering — RRT if refractory
- Compartment syndrome (pain on passive stretch + tense compartment + paraesthesia; pulselessness is LATE) = SURGICAL EMERGENCY — fasciotomy is the only effective treatment; decompress when the delta pressure (diastolic minus compartment pressure) falls under 30 mmHg
- Hypocalcaemia is COMMON (41% of severe cases, Ca ≤2.00 mmol/L) and usually asymptomatic — management is judicious: calcium homeostasis is biphasic, with recovery-phase REBOUND hypercalcaemia recognised — reserve IV calcium for symptomatic hypocalcaemia or hyperkalaemic ECG changes
- Statins + gemfibrozil + other interacting drugs = high-risk combination for rhabdomyolysis — monitor CK and stop at first sign of muscle pain
Meet the patient
A 28-year-old man is extricated after eight hours under a collapsed wall, both lower limbs and his pelvis crushed. He arrives bradycardic at 46, blood pressure 78/50, GCS 14. The ECG shows a wide QRS with peaked T waves merging towards a sine wave. The venous gas reads K 8.2 mmol/L, pH 7.08, lactate 9, and the catheter drains dark tea-coloured urine — the severe end of the published spectrum, in which hyperkalaemia, hypocalcaemia, acute renal failure and pigmenturia cluster together.[3][2]
The question that decides whether he lives the next ten minutes is the question that decides every rhabdomyolysis: is the potassium still being released from dying muscle? Because if it is, no single insulin-dextrose bolus will hold it. Hold that thought, and the fluid-first, calcium-paradox, fasciotomy-clock logic below falls into place.[8][9]
References20ShowHide
- [1]Stahl K, Rastelli E, Schoser B, et al. A systematic review on the definition of rhabdomyolysis. J Neurol, 2020.PMID 30617905
- [2]Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJA, de Visser M Rhabdomyolysis: review of the literature. Neuromuscul Disord, 2014.PMID 24946698
- [3]Veenstra J, Smit WM, Krediet RT, Arisz L Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant, 1994.PMID 7970089
- [4]Melli G, Chaudhry V, Cornblath DR Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine (Baltimore), 2005.PMID 16267412
- [5]Mikkelsen TS, Toft P Prognostic value, kinetics and effect of CVVHDF on serum of the myoglobin and creatine kinase in critically ill patients with rhabdomyolysis. Acta Anaesthesiol Scand, 2005.PMID 15954972
- [6]Better OS Early fluid resuscitation in patients with rhabdomyolysis. Nat Rev Nephrol, 2011.PMID 21587227
- [7]Cho YS, Lim H, Kim SH Comparison of lactated Ringer's solution and 0.9% saline in the treatment of rhabdomyolysis induced by doxylamine intoxication. Emerg Med J, 2007.PMID 17384382
- [8]Batterink J, Cessford TA, Taylor RA, et al. Pharmacological interventions for the acute management of hyperkalaemia in adults. Cochrane Database Syst Rev, 2015.PMID 35658162
- [9]Harel Z, Kamel KS. Optimal Dose and Method of Administration of Intravenous Insulin in the Management of Emergency Hyperkalemia: A Systematic Review. PLoS One, 2016.PMID 27148740
- [10]Geldermann N, et al. Acute hyperkalaemia in emergency care: evidence-based approaches. Emerg Med J, 2026.PMID 41506858
- [11]McQueen MM, Court-Brown CM. Compartment monitoring in tibial fractures. The pressure threshold for decompression. J Bone Joint Surg Br, 1996.PMID 8898137
- [12]Schmidt AH Acute Compartment Syndrome. Orthop Clin North Am, 2016.PMID 27241376
- [13]Richards JR, Wang CG, Fontenette RW, et al. Rhabdomyolysis, Methamphetamine, Amphetamine and MDMA Use: Associated Factors and Risks. J Dual Diagn, 2020.PMID 32644906
- [14]Thompson PD, Clarkson P, Karas RH Statin-associated myopathy. JAMA, 2003.PMID 12672737
- [15]Wu J, Song Y, Li H, Chen Y Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report. Eur J Clin Pharmacol, 2009.PMID 19756555
- [16]Link E, Parish S, Armitage J, et al. SLCO1B1 variants and statin-induced myopathy--a genomewide study. N Engl J Med, 2008.PMID 18650507
- [17]Warren JD, Blumbergs PC, Thompson PD Rhabdomyolysis: a review. Muscle Nerve, 2002.PMID 11870710
- [18]Torres PA, Helmstetter JA, Kaye AM, Kaye AD Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J, 2015.PMID 25829882
- [19]Yamaji F, et al. Rhabdomyolysis: What you need to know. J Trauma Acute Care Surg, 2026.PMID 42479694
- [20]Das A, et al. Rhabdomyolysis-Induced Resistant Hypercalcemia During the Recovery Phase of Acute Kidney Injury. Cureus, 2026.PMID 42306390